Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_100FC8365112
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type.
Journal
European journal of clinical pharmacology
Author(s)
Meyer J.W., Woggon B., Baumann P., Meyer U.A.
ISSN
0031-6970 (Print)
ISSN-L
0031-6970
Publication state
Published
Issued date
1990
Peer-reviewed
Oui
Volume
39
Number
6
Pages
613-614
Language
english
Notes
Publication types: Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Keywords
Adult, Debrisoquin/metabolism, Humans, Oxidation-Reduction, Polymorphism, Genetic/genetics, Schizophrenia/drug therapy, Thioridazine/blood, Thioridazine/metabolism, Thioridazine/therapeutic use
OAI-PMH
oai:serval.unil.ch:BIB_100FC8365112
DOI
10.1007/BF00316110
Pubmed
2095351
Web of science
A1990EN35400023
Create date
12/01/2021 17:16
Last modification date
15/04/2023 6:51
Usage data